Tennessee Stem Cell Law: What the ALS Report Really Shows
Can a stem cell treatment help someone with ALS live longer or regain an ability the disease had taken away? The new Tennessee stem cell law has pushed that question into the spotlight through a powerful FOX 17 News report about Ashley Vickers, a Tennessee mother who has lived with ALS for a decade.1 Her […]
Longeveron Laromestrocel Therapy Shows Promise for Alzheimer’s Inflammation
Are you or a loved one watching memory slip away while treatments seem to fall short? The heartbreak of Alzheimer’s disease is tied to progressive brain inflammation that damages healthy tissue over time. For years, finding a way to stop this destructive inflammation has been a massive challenge for researchers and families alike. We know […]
RocketCell Enhances Stem Cell Recovery and Organoid Survival
Have you ever spent months nurturing a delicate stem cell line, only to lose half of your cells during a routine thaw or passage? The frustration of poor cell viability after cryopreservation or enzymatic dissociation is a common hurdle in regenerative medicine. We know the pain of inconsistent experimental outcomes and the setbacks they cause […]
MUSE Cells Explained: Dr. Joy Kong on Anti-Aging and Stem Cell Therapy
Are MUSE cells the next big shift in regenerative medicine, or are they another stem cell buzzword wrapped in shiny packaging? That is the honest question patients should ask before getting excited. In a video from The Dr. Joy Kong Podcast titled “Anti-Aging, Zero Rejection, and the Future of Stem Cell Therapy,” Dr. Joy Kong […]
REPROCELL Wins MSCRF Award to Advance Hypoimmune iPSC Platforms
What happens when cell therapy needs to reach more patients, but manufacturing and immune compatibility still act like locked gates? That is the tension behind REPROCELL’s new Commercialization Award from the Maryland Stem Cell Research Fund, which will support work on hypoimmune iPSC platforms for clinical applications.1 This is not a flashy promise about a […]
NOVAKnee Program Names Made Scientific as Manufacturer for Living Biologic Knee Replacement
Made Scientific will manufacture Columbia’s NOVAKnee implants for a Phase 1 trial expected in 2028 under FDA oversight.
3D-Bioprinted Stem Cell Scaffolds for Bone Repair: What Science Shows So Far
New preclinical research explores 3D-bioprinted stem cell scaffolds for bone repair, but it is not clinic-ready yet.
Family-Donor Stem Cells for Epidermolysis Bullosa: Early Trial Results Explained
A pediatric trial reported family-donor MSCs were safe in RDEB and improved symptoms. Here is what the evidence means.
Stem Cells for Stroke Recovery: New Study Shows Brain Repair in Mice
Preclinical research shows iPSC-derived neural progenitor cells helped repair stroke injury in mice. Here is what patients should know.
iPSC-Derived Immune Cells From a New Bioreactor: Why 40 Million Macrophages a Week Matters
A new bioreactor method may produce 40 million iPSC-derived macrophages weekly for research and therapy development.